fbpx

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
stomach cancer illustration

Immune-Related Adverse Events and Efficacy of Checkpoint Inhibitors in Gastrointestinal Cancer

In a recent study, patients with gastrointestinal cancers who had immune-related adverse events while taking checkpoint inhibitors had progression-free survival of 32 months vs. 4 months in those who did not have side effects.

Read Source
X